Low‐Affinity NMDA Receptor Antagonists
- 1 October 1997
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 825 (1) , 220-231
- https://doi.org/10.1111/j.1749-6632.1997.tb48432.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A controlled trial of remacemide hydrochloride in Huntington's diseaseMovement Disorders, 1996
- ARL-15896, a NovelN-Methyl-D-aspartate Receptor Ion Channel Antagonist: Neuroprotection against Mitochondrial Metabolic Toxicity and Regional PharmacologyExperimental Neurology, 1996
- N‐Methyl‐d‐Aspartate‐ or Glutamate‐Mediated Toxicity in Cultured Rat Cortical Neurons Is Antagonized by FPL 15896ARJournal of Neurochemistry, 1995
- Effects of anticonvulsants in a novel operant learning paradigm in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agentsEpilepsy Research, 1995
- Regional Variations in the Pharmacology of NMDA Receptor Channel Blockers: Implications for Therapeutic PotentialJournal of Neurochemistry, 1995
- The NMDA Receptor, NMDA Antagonists and Epilepsy TherapyDrugs, 1992
- A new model of temporary focal neocortical ischemia in the rat.Stroke, 1992
- Antiepileptic Drug ActionsEpilepsia, 1989
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989